A paradigm shift in asthma management is required

What is it about?

A paradigm shift in asthma management which addresses the inherent problems associated with the use of short acting beta-agonist therapy is required. Consideration needs to be given to replacing short acting beta-agonist reliever therapy reliever with ICS/fast-onset beta agonist reliever therapy across the range of asthma severity.

Featured Image

Photo by Hush Naidoo on Unsplash

Photo by Hush Naidoo on Unsplash

Why is it important?

ICS/fast-onset beta agonist reliever therapy is both safer and more effective than short acting beta-agonist therapy in adult asthma, across the spectrum of severity. A paradigm change in the approach to asthma management that incorporates this evidence is now required.